Display Settings:


Send to:

Choose Destination
Neurology. 2006 Jun 13;66(11):1766-9.

Endothelial dysfunction in MELAS improved by l-arginine supplementation.

Author information

  • 1Department of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka, Japan. yasukoga@med.kurume-u.ac.jp


The authors evaluated endothelial function in patients with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke) by flow-mediated vasodilation (FMD) and found a significant decrease vs controls. Two years of supplementation with oral l-arginine, a nitric oxide precursor, significantly improved endothelial function to control levels and was harmonized with the normalized plasma levels of l-arginine in patients. l-Arginine therapy improved endothelial dysfunction and showed promise in treating strokelike episodes in MELAS.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk